FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
Larry Pierce, director of cybersecurity and information security officer for Atlantic Health, unpacks how the growth of artificial intelligence is reshaping…
Headline
U.S. and international agencies Jan. 14 released guidance on secure connectivity for operational technology environments. Examples of OT environments in health…
Headline
The AHA Jan. 14 expressed support for the Rural Hospital Cybersecurity Enhancement Act (S. 2169), legislation that would direct the Department of Health and…
Headline
The FBI Jan. 8 released an alert on evolving threat tactics by Kimsuky, a North Korean state-sponsored cyber threat group. As of last year, the group…
Headline
The Cybersecurity and Infrastructure Security Agency Dec. 11 released an update to its voluntary Cybersecurity Performance Goals, which includes measurable…
Headline
U.S. and international agencies are warning of potential cyberattacks on health care and other critical infrastructure from state-sponsored cyber actors in…